Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer’s disease

被引:0
作者
Federico Verde
Ilaria Milone
Antonella Dubini
Claudia Colombrita
Alberto Perego
Federica Solca
Alessio Maranzano
Emilio Ciusani
Barbara Poletti
Antonia Ratti
Erminio Torresani
Vincenzo Silani
Nicola Ticozzi
机构
[1] IRCCS Istituto Auxologico Italiano,Department of Neurology and Laboratory of Neuroscience
[2] Università degli Studi di Milano,Department of Pathophysiology and Transplantation, Dino Ferrari Center
[3] IRCCS Istituto Auxologico Italiano,Department of Laboratory Medicine, Laboratory of Clinical Chemistry
[4] Fujirebio Europe N.V.,Laboratory of Neurological Biochemistry and Neuropharmacology
[5] Fondazione IRCCS Istituto Neurologico Carlo Besta,Department of Oncology and Hemato
[6] Università degli Studi di Milano,Oncology
[7] Università degli Studi di Milano,Department of Medical Biotechnology and Translational Medicine
来源
Neurological Sciences | 2023年 / 44卷
关键词
Alzheimer’s disease (AD); Biomarkers; Plasma; Amyloid; Aβ42; Aβ40;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3287 / 3290
页数:3
相关论文
共 28 条
[1]  
Brand AL(2022)The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review Alzheimers Res Ther 14 195-e56
[2]  
Lawler PE(2023)Pre-analytical variability of the Lumipulse immunoassay for plasma biomarkers of Alzheimer's disease Clin Chem Lab Med 61 e53-713
[3]  
Bollinger JG(2023)Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients Neurol Sci 44 709-496
[4]  
Musso G(2021)Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group Lancet Neurol 20 484-612
[5]  
Cosma C(2009)A new equation to estimate glomerular filtration rate Ann Intern Med 150 604-43
[6]  
Zaninotto M(2023)Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: important considerations for clinical trials and practice Alzheimers Dement 19 36-1140
[7]  
Gabelli C(2022)Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities Alzheimers Dement 18 1128-undefined
[8]  
Basso D(2023)Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer's disease Front Aging Neurosci 15 1150510-undefined
[9]  
Plebani M(undefined)undefined undefined undefined undefined-undefined
[10]  
Giacopuzzi Grigoli E(undefined)undefined undefined undefined undefined-undefined